Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Clozapine-Induced Drop-Attack and Myoclonus
German Journal of Psychiatry, 01/22/08
Dhar R et al. - The types of seizures that can be precipitated by the administration of clozapine are varied, including tonic-clonic, myoclonic, and atonic seizures; and, myoclonic seizures may presage tonic-clonic seizures. Because of the eclectic pathogenesis of these diverse seizures, a broad-spectrum anticonvulsant agent is preferable. Valproic acid and lamotrigine are thus first-line drugs for the treatment of clozapine -induced seizures. Plasma clozapine levels and EEG findings may be of limited practical value in predicting or diagnosing seizures
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
Journal of Clinical Oncology, 12/04/09
Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES)
International Journal of Andrology, 12/04/09
Atazanavir-Associated Choledocholithiasis Leading to Acute Hepatitis in an HIV-Infected Adult
Annals of Pharmacotherapy, 12/03/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
Schizophrenia Research, 12/06/09
Effects of Methylphenidate on Cerebral Glucose Metabolism in Patients With Impaired Consciousness After Acquired Brain Injury
Clinical Neuropharmacology, 12/05/09
Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Clinical Neuropharmacology, 12/05/09
Sponsor
Article Search
Sponsor


See Latest Articles


